Clinical trial Recruiting at 1 site Interventional Ages 45 to 55 Women only

Intermittent fasting for mental health during perimenopause

Official title: Impact of Intermittent Fasting on the Mental Health of Perimenopausal Women

Run by American University of Beirut Medical Center · NCT07481513 · Data updated 2026-11-12

This trial will see if a 16/8 intermittent fasting plan helps improve mental health for women aged 45–55 who are in perimenopause.

Quick facts

Study typeInterventional
Ages45 Years to 55 Years
SexWomen only
Enrollment140 (estimated)
SponsorAmerican University of Beirut Medical Center
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Beirut)
StatusRecruiting
StartedSeptember 23, 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedMarch 19, 2026
Trial IDNCT07481513 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 45–55 in perimenopause by STRAW criteria and the Menopausal Rating Scale, who speak English, are not on hormone therapy, and do not have major uncontrolled medical or current formal psychiatric conditions.

Probably not a fit

Women currently using hormone replacement therapy, with uncontrolled diabetes or other severe medical conditions, with a current DSM-5 psychiatric diagnosis, who have had surgical menopause, or who cannot attend visits at the Beirut center are unlikely to be eligible or to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This six-month randomized controlled trial at the American University of Beirut Medical Center will randomly assign about 98 perimenopausal women aged 45–55 to either a 16/8 intermittent fasting schedule or to follow Lebanese food-based dietary guidelines. Mental health outcomes will be measured with validated questionnaires and other standardized tools, and group differences will be analyzed using independent t-tests. Key exclusions include current hormone replacement therapy, uncontrolled major medical conditions, current DSM-5 psychiatric diagnoses, dementia, surgical menopause, pregnancy, and non–English speakers. The study aims to determine whether intermittent fasting offers a practical non-pharmacologic approach to improve mood, sleep, and cognitive symptoms during the perimenopausal transition.

Why it matters

Potential benefit: If successful, intermittent fasting could provide a non-drug option to reduce mood symptoms, improve sleep, and sharpen thinking for women in perimenopause.

How similar studies have gone: Some small studies in general adult populations suggest intermittent fasting can improve mood and cognition, but its effects specifically in perimenopausal women are largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants eligible in this study will be women between the ages of 45 and 55 who are in the perimenopausal stage as defined by the STRAW criteria and confirmed using the Menopausal Rating Scale (MRS).

Exclusion Criteria:

* Currently using hormone replacement therapy
* Diagnosed with severe medical conditions that could interfere with fasting, including uncontrolled diabetes, heart disease, hypertension, cancer or kidney disease
* Have a current formal mental health diagnosis as defined by the DSM-5, regardless of whether they are receiving medication or therapy
* Experiencing any form of dementia
* Have undergone surgical menopause, have premature ovarian failure, are currently undergoing chemotherapy or radiotherapy, or are ovarian cancer survivors
* Are currently pregnant. undergoing treatment for endometriosis, have significant thyroid disorders, or are on any form of hormone therapy
* Do not speak English
* Participants who score greater than 0 on question 9 of the PHQ-9 (including suicidal ideation) will be removed from the trial and provided with mental health referrals to NGOs for support.

Where it's running

  • American University of Beirut Medical Center
    Beirut, Lebanon
    Recruiting

Study contacts

  • Principal investigator: Nadia T Dandan, PsyD — American University of Beirut Medical Center
  • Study coordinator: Nadia T Dandan, PsyD
  • Email: nd55@aub.edu.lb
  • Phone: +9613795428

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.